-
1 Comment
SDS Biotech K.K is currently in a long term uptrend where the price is trading 32.7% above its 200 day moving average.
From a valuation standpoint, the stock is 7.4% cheaper than other stocks from the Basic Materials sector with a price to sales ratio of 0.7.
SDS Biotech K.K's total revenue sank by 3.2% to $3B since the same quarter in the previous year.
Its net income has increased by 49.3% to $422M since the same quarter in the previous year.
Based on the above factors, SDS Biotech K.K gets an overall score of 3/5.
| Exchange | TSE |
|---|---|
| CurrencyCode | JPY |
| Sector | Basic Materials |
| Industry | Agricultural Inputs |
| ISIN | JP3163200003 |
| Market Cap | 11B |
|---|---|
| PE Ratio | None |
| Beta | 0.96 |
| Dividend Yield | 1.7% |
| Target Price | None |
SDS Biotech K.K. engages in the production, import, and sale of agricultural chemicals, industrial biocides, public health products, and specialty chemicals. It provides fungicides, paddy herbicides, non-crop herbicides, biological products, and specialty products. The company was founded in 1968 and is headquartered in Tokyo, Japan. SDS Biotech K.K. is a subsidiary of Idemitsu Kosan Co.,Ltd.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 4952.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
